SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $540,681,000 | +27.1% | 5,543,741 | +20.9% | 0.07% | +25.5% |
| Q4 2014 | $425,357,000 | +59.3% | 4,584,091 | +18.1% | 0.06% | +52.8% |
| Q3 2014 | $267,076,000 | -29.4% | 3,883,041 | +7.5% | 0.04% | -29.4% |
| Q2 2014 | $378,391,000 | +69.7% | 3,610,601 | +34.4% | 0.05% | +64.5% |
| Q1 2014 | $222,937,000 | +13.4% | 2,686,964 | -11.5% | 0.03% | +10.7% |
| Q4 2013 | $196,569,000 | -2.5% | 3,037,219 | -4.6% | 0.03% | -9.7% |
| Q3 2013 | $201,618,000 | +71.1% | 3,184,628 | +13.5% | 0.03% | +63.2% |
| Q2 2013 | $117,856,000 | – | 2,806,087 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|